| NeuroDiagnostic Institute | |
|---|---|
| Indiana Family and Social Services Administration | |
 Neurodiagnostic Institute in 2022 | |
|
| |
| Geography | |
| Location | 5435 16th Street, Indianapolis, Indiana, United States |
| Coordinates | 39°47′18″N 86°4′35″W / 39.78833°N 86.07639°W |
| Organization | |
| Funding | State |
| Type | Psychiatric |
| Services | |
| Beds | 159 |
| History | |
| Opened | 2019 |
| Links | |
| Website | NeuroDiagnostic Institute |
| Lists | Hospitals in Indiana |
The NeuroDiagnostic Institute (NDI) is a state psychiatric hospital located in Indianapolis, Indiana. The hospital serves Central Indiana, having replaced the now-closed Larue D. Carter Memorial Hospital. [1] NDI is operated by the State of Indiana Family and Social Services Administration in partnership with the private Community Health Network. [2] The hospital, built on the Community Hospital East campus, opened on March 15, 2019, as Indiana's first new state psychiatric hospital in decades. [3]
History
NDI was announced in 2015 as the successor to the State's aging Larue D. Carter Memorial Hospital. [3] Compared to Larue, NDI has a larger staff (500 versus 350), more beds for pediatric patients (65 versus 42), and significantly more security cameras. [1] [4] Completed at a cost of $118 million, NDI is designed to serve 1,500 patients annually for acute and chronic mental illness, chronic addictions, adolescent autism spectrum disorders, traumatic brain injuries, and neuro-degenerative illnesses such as Alzheimer’s disease. [1] [4]
See also
References
- ^ a b c Rudavsky, Shari (March 14, 2019). "How Indiana's new mental health hospital will change psychiatric care". The Indianapolis Star. Retrieved 6 April 2021.
- ^ "NeuroDiagnostic Institute". IN.gov. IN.gov. Retrieved 6 April 2021.
- ^ a b Sheridan, Jill (15 March 2019). "NeuroDiagnostic Institute Opens, First New Psychiatric Hospital In Decades". WFYI. Retrieved 6 April 2021.
- ^ a b "NeuroDiagnostic Institute and Advanced Treatment Center" (PDF). IN.gov. IN.gov. Retrieved 6 April 2021.